Drug Shortage Report for PEGALAX
Report ID | 155275 |
Drug Identification Number | 02328232 |
Brand name | PEGALAX |
Common or Proper name | Polyethylene Glycol 3350 Powder for oral solution |
Company Name | ARALEZ PHARMACEUTICALS CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | POLYETHYLENE GLYCOL 3350 |
Strength(s) | 100% |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | ORAL ORAL |
Packaging size | carton of 14 sachets |
ATC code | A06AD |
ATC description | DRUGS FOR CONSTIPATION |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2022-02-18 |
Actual start date | 2022-02-18 |
Estimated end date | 2022-03-09 |
Actual end date | 2022-03-09 |
Shortage status | Resolved |
Updated date | 2022-03-10 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6733 MISSISSAUGA RD, SUITE 800 MISSISSAUGA, ONTARIO CANADA L5N 6J5 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2022-03-10 | English | Compare |
v8 | 2022-03-09 | French | Compare |
v7 | 2022-03-09 | English | Compare |
v6 | 2022-03-09 | English | Compare |
v5 | 2022-03-03 | French | Compare |
v4 | 2022-03-03 | English | Compare |
v3 | 2022-02-19 | English | Compare |
v2 | 2022-02-18 | French | Compare |
v1 | 2022-02-18 | English | Compare |
Showing 1 to 9 of 9